Concepedia

Author

M. Keiserman

Pontifícia Universidade Católica do Rio Grande do Sul

Also Known As

E. F. Mysler, M Keiserman, M. Keiserman, M. W. Keiserman, M.W. Keiserman, MW Keiserman, Mauro Keiserman

31

Publications

946

Citations

8

H-Index

6

Concepts

All Affiliations

Pontifícia Universidade Católica do Rio Grande do SulBristol-Myers Squibb (United States)University of Oklahoma Health Sciences CenterCliniques Universitaires Saint-LucUniversité Paris Cité
MK

About

M. Keiserman is an author at Pontifícia Universidade Católica do Rio Grande do Sul specializing in rheumatology, rheumatic diseases, and rheumatoid arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

22

2

Pharmacology

1

1

22

3

Rheumatology

1

1

22

4

Rheumatic Diseases

1

1

22

5

Psoriatic Arthritis

1

1

22

M. Keiserman

×

7

Publications

907

Citations

7

H-Index

YearCitations

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

Michael Schiff, M. Keiserman, C. Codding,

Annals of the Rheumatic Diseases

2007

536

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

M. C. Genovese, A. Covarrubias, G. Léon,

Arthritis & Rheumatism

2011

194

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

Michael Schiff, M. Keiserman, C. Codding,

Annals of the Rheumatic Diseases

2011

55

Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients.

Thelma Larocca Skare, N Leite, Adriana Bruscato Bortoluzzo,

PubMed

2012

40

Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study

Daniel J. Wallace, Kathryn Hobbs, Megan E. B. Clowse,

Arthritis Care & Research

2015

39

Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context

Enrique R. Soriano, Claudio Galarza-Maldonado, Mario H. Cardiel,

Lara D. Veeken

2008

22

OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Mark C. Genovese, Apinya Lertratanakul, J. Anderson,

Annals of the Rheumatic Diseases

2020

21

Page 1